ORIGINAL RESEARCH
Published on 14 Apr 2023
Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244
doi 10.3389/fcimb.2023.1117844
- 4,624 views
- 6 citations
- Frontiers in Cellular and Infection Microbiology
- Molecular Bacterial Pathogenesis
- Research Topics
- Pseudomonas aeruginosa: Recent Advances in Virulence Factors, Prevention, and Treatment
Pseudomonas aeruginosa: Recent Advances in Virulence Factors, Prevention, and Treatment
9,623
Total downloads
39k
Total views and downloads
Articles
MINI REVIEW
Published on 28 Nov 2022
Modulation of the immune response by the Pseudomonas aeruginosa type-III secretion system
doi 10.3389/fcimb.2022.1064010
- 5,221 views
- 22 citations
REVIEW
Published on 22 Jul 2022
The role of the Pseudomonas aeruginosa hypermutator phenotype on the shift from acute to chronic virulence during respiratory infection
doi 10.3389/fcimb.2022.943346
- 4,539 views
- 17 citations
REVIEW
Published on 08 Jul 2022
What Is New in the Anti–Pseudomonas aeruginosa Clinical Development Pipeline Since the 2017 WHO Alert?
doi 10.3389/fcimb.2022.909731
- 14,128 views
- 43 citations
MINI REVIEW
Published on 23 Jun 2022
ExlA: A New Contributor to Pseudomonas aeruginosa Virulence
doi 10.3389/fcimb.2022.929150
- 3,045 views
- 3 citations
ORIGINAL RESEARCH
Published on 15 Jun 2022
Gentamicin Augments the Quorum Quenching Potential of Cinnamaldehyde In Vitro and Protects Caenorhabditis elegans From Pseudomonas aeruginosa Infection
doi 10.3389/fcimb.2022.899566
- 3,754 views
- 33 citations
ORIGINAL RESEARCH
Published on 15 Jun 2022
Genomic Characterization of Mutli-Drug Resistant Pseudomonas aeruginosa Clinical Isolates: Evaluation and Determination of Ceftolozane/Tazobactam Activity and Resistance Mechanisms
doi 10.3389/fcimb.2022.922976
- 2,875 views
- 11 citations
